1. Stocks
  2. Corvus Pharmaceuticals Inc
  3. Swot
swot-logo

Corvus Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Corvus Pharmaceuticals Inc has 22 Strengths, 6 Weaknesses, 3 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Consistent Highest Return Stocks over Five Years

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Stock gained more than 20% in one month

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Volume Shockers

High Volume, High Gain

Biggest Price Gainers from Open

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Profit to Loss Companies

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Stocks rising sharply on very low month volumes

Mutual Funds Decreased Shareholding in Past Month

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks